Cargando…

Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed

Detalles Bibliográficos
Autor principal:	Naser Moghadasi, Abdorreza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436422/ https://www.ncbi.nlm.nih.gov/pubmed/34543859 http://dx.doi.org/10.1016/j.msard.2021.103263

Ejemplares similares

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Neuroplasticity in Early Onset Multiple Sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

Attitudes toward vaccination in patients with multiple sclerosis: A report from Iran
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Multiple Sclerosis in Parsis: A Historical Issue
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

Encephalopathy associated with COVID-19 in a patient with multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2021)

A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients
por: Moghadasi, Abdorreza Naser
Publicado: (2021)

COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis
por: Abbasi, Naghmeh, et al.
Publicado: (2022)

Acute attack in a patient with multiple sclerosis 2 days after COVID vaccination: a case report
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

Can multiple sclerosis as a cognitive disorder influence patients’ dreams?
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2013)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis
por: Jafari, Zahra, et al.
Publicado: (2018)

Bacterial meningitis in a patient with multiple sclerosis receiving Tysabri
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2016)

A Smartphone-based Application for Self-Management in Multiple Sclerosis
por: Mokhberdezfuli, Mahdieh, et al.
Publicado: (2021)

Can pulse steroid therapy increase the risk of infection by COVID-19 in patients with multiple sclerosis?
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2021)

Redox Imbalance in CD4+ T Cells of Relapsing-Remitting Multiple Sclerosis Patients
por: Tavassolifar, Mohammad Javad, et al.
Publicado: (2020)

Initial clinical presentation of multiple sclerosis with concurrent COVID-19 infection: Case report and literature review
por: Ebadi, Zahra, et al.
Publicado: (2022)

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report
por: Arzani, Mahsa, et al.
Publicado: (2018)

The co-occurrence of multiple sclerosis and Evans syndrome: A case report
por: Salehizadeh, Saeideh, et al.
Publicado: (2020)

Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
por: Paybast, Sepideh, et al.
Publicado: (2022)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

Is Monkeypox a Concern in Multiple Sclerosis Patients? A Letter to Editor
por: Asadollahzadeh, Elnaz, et al.
Publicado: (2022)

Beta-thalassemia intermedia with ischemic transients misdiagnosed as multiple sclerosis: A case report
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey
por: Fattahi, Mohammad Reza, et al.
Publicado: (2022)

Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
por: Rezaeimanesh, Nasim, et al.
Publicado: (2020)

Iranian neurological events: The 20(th) Iranian Congress of Neurology and Electrophysiology
por: Togha, Mansoureh, et al.
Publicado: (2013)

Epidemiology of multiple sclerosis in Qom: Demographic study in Iran
por: Rezaali, Saeed, et al.
Publicado: (2013)

Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS)
por: GHAJARZADEH, Mahsa, et al.
Publicado: (2014)

A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis
por: Shokati, Ameneh, et al.
Publicado: (2021)

Implementing coronavirus disease 2019 scale-up registry protocol in national multiple sclerosis registry system of Iran
por: Eskandarieh, Sharareh, et al.
Publicado: (2021)

Comment on “The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Is anemia a probable cause of fatigue in patients with multiple sclerosis?
por: Mir-Reza, Soha, et al.
Publicado: (2013)

Predictors of suicidal ideation among Iranian patients with multiple sclerosis
por: Asgarian, Fatemeh Sadat, et al.
Publicado: (2020)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mdsitgg1qnfbc9k9db9nccstn3